SK Hynix's Seoul Leg Rebounds Into Its $26.5B Nasdaq Debut and Live HBM4 Shipments

A Rebound Wearing a Debut's Clothes

SKHX is up 10.87% over 22 hours to $1,315, but don't mistake the tape for a fresh single headline. This is the Seoul-listed common share — the oracle prices SK Hynix's KRW stock into USD at the prevailing FX rate — bouncing off a brutal drawdown of roughly 38% from the June 25 record of 2,987,000 won. The whole Korean chip complex is leading the global tape again: SK Hynix and AMD both caught bids as Korea became the new catalyst for global chip stocks. The domestic flow is the tell — Korea's National Pension Service made SK Hynix its single most-bought stock in July, net buying roughly ₩440 billion ($298M) into the dip. With the name still up around 208% year-to-date, this is a violent stock reasserting a trend, not calling a bottom on news.

The $26.5B Nasdaq Debut Reframes the Name

The backdrop that matters: SK Hynix just placed 177.9 million ADRs at $149 to raise about $26.51 billion, one of the largest US share sales on record, with the book covered roughly seven times over. The ADRs (SKHY) opened near $170 and touched $177 on debut. The nuance every perp trader needs: SKHX tracks the Seoul-listed common share in won, not the New York ADR. You are long the underlying leg, and whatever premium or discount opens between Seoul and the freshly listed ADR is now a live arbitrage rather than a theoretical one. CNBC framed the listing as a trillion-dollar chipmaker arriving on US markets — that US bid is fresh demand the Seoul line simply did not have a month ago.

HBM4 Is the Fundamental, Not the Narrative

Underneath the listing noise is a real product cycle. SK Hynix has begun volume output of its 12-layer HBM4 chips, which have already passed Nvidia's quality certification, with deliveries set to accelerate from September. This is the company that controls more than half — around 56% — of the HBM market Nvidia depends on. With DRAM makers reportedly able to meet only 75-80% of demand, the memory shortage is the entire bull case, and it is why Barclays carries an Overweight and a $330 target on the ADRs. The July 15 leg of this rebound was mostly Seoul shares tracking US tech gains on soft inflation data — but HBM4 shipping in volume is the part that outlasts any single macro session.

July 29 Is the Next Print

The clean catalyst sits on the calendar: Q2 earnings land July 29, and the tape is positioning into it — the 14% pop was framed explicitly as pre-earnings positioning as chip names rebounded. Two things to keep honest about. First, this is a synthetic on a KRW asset: with USD/KRW near multi-year weakness, FX can push SKHX around independent of what the Seoul stock actually does in won. Second, a name that has already run around 208% year-to-date and now trades with a US ADR overhang can gap both ways on a guidance miss. The rebound has real fundamentals behind it — HBM4, the debut, pension flows — but July 29 is where the AI-memory supercycle either confirms or gets repriced.